MERCK Stock Quote
$56.76 
Change:
0.00 %Chge:
0.00% Vol:
898,185
End Of Day Prices
High: 57.08 | Low: 56.31 | Open: 56.53 | Close: 56.76
52 Wk High: 59.78 | 52 Wk Low: 44.81 | Todays Pivot: 56.72
Sector: Healthcare and Pharmaceuticals
Merck Company Profile
Merck & Co (MRK) is a global pharmaceutical giant that manufactures key health products for human and animal health. They are the second largest company worldwide, as measured by market share. Grossing over $27 billion dollars annually, Merck are well known for producing leading scientific research and powerful pharmaceutical products. Since merging with Schering-Plough in 2009, the company has combined product lines for what they term is a “stronger pipeline”
» Read More About Merck
MRK Chart
You need Flash Player to see the chart, please download from the link below
Related Healthcare and Pharmaceuticals Companies
Above is a small selection of related companies to Merck which compete alongside MRK within the Healthcare and Pharmaceuticals sector.
Online News For Merck
|
Merck's Sales Fall, but Its Confidence Rises - Wall Street Journal
Tue, 29 Jul 2014 14:41Yet Merck executives expressed confidence in the pharmaceutical company's future, saying its laboratories and deal makers would find new drugs to refresh an aging portfolio. They singled out a cancer immunotherapy, which could be approved by late ...
|
|
Merck: No Tax Inversions, Just Bolt-on M&A - Wall Street Journal (blog)
Tue, 29 Jul 2014 15:21“Merck is not interested in pursuing a business development deal either solely or primarily for the specific purpose of tax inversions,” said Kenneth Frazier, Merck's CEO, on the conference call. “Our strategy is built on innovation in the pipeline ...
|
|
Merck CEO Seeks Drug Add-Ons, Not Large Tax-Inversion Deals - Bloomberg
Tue, 29 Jul 2014 15:37Merck & Co. (MRK), the second-biggest U.S. drugmaker, is staying in the U.S. and sticking to a bolt-on acquisition strategy, shunning the route taken by its biggest rival, Pfizer Inc. (PFE). Merck is not interested in large scale purchases that are ...
|
|
Merck quarterly profit beats estimates; shares gain - Reuters
Tue, 29 Jul 2014 14:39Merck, the No. 2 U.S. drugmaker, has been busy with deal-making in recent months, including an agreement to sell its consumer care business to Germany's Bayer AG for $14.2 billion. In June, it agreed to buy Idenix Pharmaceuticals Inc for $3.85 billion ...
|
|
3 Reasons To Buy Merck For The Long Term - Benzinga
Thu, 31 Jul 2014 21:02Merck (NYSE: MRK) is a blue chip "Big Pharma" stock that is up for the last week, month, quarter, six months and year of market action. For 2014, Merck has risen by nearly 19 percent. There are three reasons for long-term investors to buy shares of ...
|
|
Interesting September Stock Options for Merck - Forbes
Mon, 28 Jul 2014 16:13Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Merck & Co Merck & Co., Inc (NYSE: MRK). So this week we highlight one interesting put contract, and one interesting call contract ...
|
Want To Add This Quote To Your Site?
With our stock widgets you can add a Merck quote to your website to keep your users up to date with the market. We have a variety of different styled widgets for MRK to choose from. Visit here to build your stock quote widget »
